GLOBAL BIOENERGIES: PUBLICATION OF THE HALF-YEAR RESULTS TO 30/06/2016
(Thomson Reuters ONE) -
GLOBAL BIOENERGIES: PUBLICATION OF THE HALF-YEAR RESULTS TO 30/06/2016
Net loss for the Group of ?6.7 million in the first half of 2016
?9.1 million in cash at 30 June 2016
Evry, 22 September 2016 - Global Bioenergies (Alternext Paris: ALGBE) publishes
its audited half-year financial statements to 30 June 2016, together with its
registration document including the Group's consolidated financial statements at
31 December 2015 and 30 June 2016.
The report presenting the Company's business and accounts for the first half of
2016, as well as the report containing the Group's consolidated financial
statements for the same period, are available on the Global Bioenergies website
in the "Investors/Regulated information" section. The registration document
filed with the French Financial Markets Authority (AMF) on 22 September is
available in the same section and on the AMF website.
* Group Profit & Loss Account as at 30 June 2016
+------------------------------------------------------------------------------+
| |
| |
|In ? thousands from 01/01/16 from 01/07/15 from 01/01/15|
| |
|GROUP CONSOLIDATED FINANCIAL to 30/06/16 to 31/12/15 to 30/06/15|
|STATEMENTS |
| |
| 6 months 6 months 6 months|
| |
| |
+------------------------------------------------------------------------------+
| |
| |
|Operating income 767 1,467 761|
| |
|Operating expenses 7,200 7,439 6,801|
| |
|Operating profit (loss) (6,433) (5,973) (6,040)|
| |
| |
| |
|Financial profit (loss) (245) (189) (69)|
| |
|Exceptional profit (loss) (32) (89) (20)|
| |
| |
| |
|Income tax NA* (1,985) NA*|
| |
| |
+------------------------------------------------------------------------------+
|Net profit (loss) (6,709) (4,266) (6,129)|
+------------------------------------------------------------------------------+
*Note: by convention, the Group does not record Research Tax Credit (Crédit
d'Impôt Recherche) in its half-year positions
The Group's operating loss over the past three six-month periods is stable at
between ?6 million and ?6.4 million, reflecting rigorous management against the
backdrop of construction of the Leuna demo plant (Germany), which is scheduled
to be delivered soon.
Operating income is dependent in particular on subsidies from the German and
French governments; ?4.4 million is slated to be received by the end of 2017.
* Group Balance Sheet as at 30 June 2016
+--------------------------------------+ +-------------------------------------+
|Assets (? thousands) 30/06/16 31/12/15| |Liabilities (? 30/06/16 31/12/15|
| | |thousands) |
+--------------------+--------+--------+ +-------------------+--------+--------+
| | | | | | | |
| | | | | | | |
|Intangible assets | 91| 106| |Capital | 159| 142|
| | | | | | | |
|Assets | 10,202| 7,230| |Share premium | 45,541| 37,817|
| | | | | | | |
|Financial assets | 144| 142| |Retained earnings |(30,066)|(19,665)|
| | | | | | | |
| | | | |Profit (loss) | (6,709)|(10,395)|
| | | | | | | |
| | | | |Equipment subsidies| 156| 0|
| | | | | | | |
| | | | | | | |
| | | | | | | |
|NON-CURRENT ASSETS | 10,437| 7,478| |EQUITY | 9,081| 7,899|
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | |PROVISIONS | 40| 30|
| | | | | | | |
| | | | | | | |
| | | | | | | |
|Inventories - | | | |Conditional | | |
|Receivables - | 2,376| 4,313| |advances and loans | 9,830| 10,440|
|Prepaid Expenses | | | | | | |
| | | | | | | |
|Cash - Marketable | 9,107| 10,418| |Trade payables and | 2,497| 3,181|
|securities | | | |related accounts | | |
| | | | | | | |
| | | | |Other debts | 473| 660|
| | | | | | | |
| | | | | | | |
| | | | | | | |
|CURRENT ASSETS | 11,483| 14,731| |PAYABLES | 12,799| 14,281|
| | | | | | | |
| | | |
+--------------------+--------+--------+ +-------------------+--------+--------+
|TOTAL ASSETS | 21,920| 22,209| |TOTAL LIABILITIES | 21,920| 22,209|
+--------------------+--------+--------+ +-------------------+--------+--------+
Capital investments for the first half of 2016 were ?3.6 million, bringing total
assets to
?10.2 million. These investments are primarily for the construction of the Leuna
demo plant.
Note that the investments made in the Leuna demo plant are financed by a bank
loan of
?4.4 million taken out in 2015 with a consortium of banks and by a ?5.7 million
subsidy granted by the German Ministry of Research, of which ?3.7 million was
yet to be received as of 30/06/2016. In addition, financing of ?9 million
dedicated to IBN-One's first renewable isobutene production plant was granted to
the Group by the ADEME's Investments for the Future Program. It is scheduled to
be paid over the next four years.
+------------------------------------------------------------------------+
| CASH-FLOW (? thousands) H1 2016 2015 2014 |
+------------------------------------------ |
| |
| |
| Operating cash-flow (4,994) (8,840) (8,009) |
| |
| Net profit (loss) (6,709) (10,395) (7,578) |
| |
| Amortisation (+) 647 979 586 |
| |
| Gain on asset disposal (-) (3) - (11) |
| |
| Change in Working Capital Requirement 1,065 576 (1,029) |
| |
| |
| |
| Investing cash-flow (3,598) (4,488) (2,798) |
| |
| Financing cash-flow 7,096 7,873 2,720 |
| |
| |
+------------------------------------------------------------------------+
Cash at 30 June 2016 was ?9.1 million, down by ?1.3 million over the half-year.
It enables the Group to cover its needs beyond the major value creation step
resulting from the production of isobutene batches at the Leuna demo plant.
* Highlights of the first half of 2016 and recent events
Industrial agreements
Historical partners Arkema and Audi both indicated that they had carried out
studies that technically validate the isobutene produced by Global Bioenergies
for paint and fuel applications, respectively.
Several agreements have been signed with new industrial players, demonstrating
the growing interest in the technology developed by Global Bioenergies:
* Arlanxeo, a world leader in synthetic rubber production, obtained a batch of
isobutene produced and purified from the Pomacle pilot site;
* Clariant, a European leader in speciality chemicals, received a batch of
isobutene and validated its specifications for a specific application, which
has not yet been revealed;
* the cosmetics giant L'Oréal is moving closer to its aim of using biosourced
ingredients with its involvement in a new project that has received ?9
million in financing from the Investments for the Future Progam. The project
is being conducted with the Cristal Union sugar group, Global Bioenergies
and their jointly held subsidiary IBN-One;
* the Swedish group Aspen secured access rights to isooctane made from
isobutene that will be produced at Leuna and by IBN-One for a speciality
fuels application (alkylate gasoline for small two- and four-stroke
engines).
Construction of the demo plant at Leuna is continuing
At the beginning of June, the Group reported that all of the demo plant's large
units had been accepted. The last construction phase consists in connecting the
different units together. The complete audit prerequisite to receiving an
operating permit is underway. During the first half of the year, the Group
stated that the performance achieved by the process implemented at the Pomacle-
Bazancourt pilot site reflected that obtained a few months earlier in the
laboratory at Evry: this preliminary success in scaling up the process provides
an excellent base on which to prepare for the Leuna demo plant start-up planned
for this autumn.
First phase of IBN-One plant engineering entrusted to Technip and IPSB
The Group has entrusted the Front End Engineering Design studyfor the first
plant to convert renewable resources into isobutene to the Technip and IPSB
groups. Technip is a world leader in energy, petrochemicals and chemical
engineering; IPSB is an engineering company specialised in sugar and
biotechnology. Plant construction could begin early 2018.
François-Henri Reynaud, Global Bioenergies Chief Financial Officer, comments:
"Nearly all the investment for the construction of the Leuna demo plant is now
behind us. The company is reporting a satisfactory cash level at 30 June 2016.
It will be sustained over the coming months thanks to significant payments from
the German and French funding secured in recent years."
Marc Delcourt, co-founder and CEO at Global Bioenergies, concludes: "Once the
Leuna demo plant is operational, Global Bioenergies will be able to sell its
technology under optimal conditions. I expect a number of renewable isobutene
production plant projects to emerge over the coming years."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in
Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its efforts on
the production of isobutene, one of the most important petrochemical building
blocks that can be converted into fuels, plastics, organic glass and elastomers.
Global Bioenergies continues to improve the performances of its process,
operates its industrial pilot, builds its demo plant in Germany, and prepares
the first full-scale plant through a Joint-Venture with Cristal Union, named
IBN-One. The company also replicated its achievement to propylene and butadiene,
two members of the gaseous olefins family, key molecules at the heart of
petrochemical industry. Global Bioenergies is listed on Alternext, Euronext
Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: (at)GlobalBioenergi
Contact
GLOBAL BIOENERGIES
François-Henri REYNAUD
Chief Financial Officer
Phone: +33 1 64 98 20 50
Email: invest(at)global-bioenergies.com
PRESS RELEASE:
http://hugin.info/166909/R/2043947/763160.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GLOBAL BIOENERGIES via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 22.09.2016 - 17:36 Uhr
Sprache: Deutsch
News-ID 496529
Anzahl Zeichen: 17127
contact information:
Town:
Evry
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GLOBAL BIOENERGIES: PUBLICATION OF THE HALF-YEAR RESULTS TO 30/06/2016"
steht unter der journalistisch-redaktionellen Verantwortung von
GLOBAL BIOENERGIES (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
